The Phase III segment would then begin with 1, 700 patients, and there is speculation that second Phase III trial might also be attempted with only earlier-stage patients.
It may prove to be unfortunate that didn't stop there when it presented the successor to its hit Galaxy S III, because the phone has a grab-bag of features that don't come together as a pleasing whole.